Log In
BCIQ
Print this Print this
 

TI-002

  Manage Alerts
Collapse Summary General Information
Company Trigemina Inc.
DescriptionIntranasal polypeptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat whole-body pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today